We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$780M
AUM Growth
+$171M
Cap. Flow
+$112M
Cap. Flow %
14.34%
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.02M
2
AVGO icon
Broadcom
AVGO
+$6.42M
3
TSM icon
TSMC
TSM
+$6.34M
4
MDC
M.D.C. Holdings, Inc.
MDC
+$6.09M
5
OTEX icon
Open Text
OTEX
+$5.5M

Top Sells

Rank Stock Value
1
FOXA icon
Fox Class A
FOXA
+$9.87M
2
FANG icon
Diamondback Energy
FANG
+$9.52M
3
HD icon
Home Depot
HD
+$7.05M
4
MET icon
MetLife
MET
+$6.8M
5
ACN icon
Accenture
ACN
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 21.53%
2 Consumer Discretionary 17.87%
3 Industrials 15.32%
4 Healthcare 12.76%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCVIW
501
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
– –
-110,800
Closed -$17.7K
SMAR
502
DELISTED
Smartsheet Inc.
SMAR
– –
-5,386
Closed -$257K
ATEK
503
DELISTED
Athena Technology Acquisition Corp. II
ATEK
– –
-216,690
Closed -$2.22M
CBRG
504
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
– –
-106,930
Closed -$1.12M
AXNX
505
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-13,955
Closed -$761K
INTE
506
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
– –
-102,210
Closed -$1.05M
GTAC
507
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
– –
-10,630
Closed -$111K
ALLG.WS
508
DELISTED
Allego N.V. Warrants
ALLG.WS
– –
-18,500
Closed -$4.58K
KDNY
509
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-30,927
Closed -$716K
VRAY
510
DELISTED
ViewRay, Inc.
VRAY
– –
-353,100
Closed -$1.22M
FMIVW
511
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
– –
-125,962
Closed -$15.7K
BTMDW
512
DELISTED
Biote Corp. Warrant
BTMDW
– –
-128,292
Closed -$53.9K
RXDX
513
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-9,455
Closed -$1.01M
BPAC
514
DELISTED
Bullpen Parlay Acquisition Company Class A Ordinary Share
BPAC
– –
-26,740
Closed -$279K
PRVB
515
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-235,000
Closed -$5.66M
YTPG
516
DELISTED
TPG Pace Beneficial II Corp.
YTPG
– –
-99,758
Closed -$995K
CZOO.WS
517
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
– –
-77,500
Closed -$403
17 18 19 20
21

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q2 2023 Portfolio in Review

As of Q2 2023, Advisory Research held 517 positions worth $780M, up 28% from $608M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Advisory Research deployed $112M of net new capital in Q2 2023, opening 169 new positions and adding to 169 existing holdings. Its largest new stake was Merck: 79,479 shares worth $9.17M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $7.05M trimmed.

  • Advisory Research's largest Q2 2023 buy was Merck: 79,479 shares worth $9.17M.
  • Advisory Research added most to Broadcom in Q2 2023, an estimated $6.42M increase.
  • Advisory Research's biggest Q2 2023 reduction was Home Depot, cutting an estimated $7.05M.
  • Advisory Research fully exited Fox Class A in Q2 2023, selling an estimated $9.87M.
  • Advisory Research's ten largest holdings make up 17% of its $780M portfolio in Q2 2023.
  • Advisory Research opened 169 new positions and closed 81 in Q2 2023.
  • Advisory Research's portfolio value rose 28% quarter-over-quarter to $780M.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.